Literature DB >> 29802082

Plasma exchange to remove heparin-induced thrombocytopenia antibodies and the use of heparin during cardiopulmonary bypass in critically ill cardiac patients.

Bhavadharini Ramu1, Rebecca J Cogswell2, Mark T Reding3, Ranjit John4, Cindy M Martin2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29802082     DOI： 10.1016/j.healun.2018.04.016

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  3 in total

Review 1.  Anticoagulating patients with high-risk acquired thrombophilias.

Authors:  Leslie Skeith
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Therapeutic plasma exchange for management of heparin-induced thrombocytopenia: Results of an international practice survey.

Authors:  Oluwatoyosi A Onwuemene; Nicole D Zantek; Marian A Rollins-Raval; Jay S Raval; Joseph E Kiss; Tina S Ipe; Maragatha Kuchibhatla; Monica B Pagano; Edward C C Wong
Journal:  J Clin Apher       Date:  2019-05-22       Impact factor: 2.821

3.  Expert consensus on the diagnosis and treatment of thrombocytopenia in adult critical care patients in China.

Authors:  Jing-Chun Song; Shu-Yuan Liu; Feng Zhu; Ai-Qing Wen; Lin-Hao Ma; Wei-Qin Li; Jun Wu
Journal:  Mil Med Res       Date:  2020-04-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.